Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

MUCINEX FAST-MAX CHEST-CONGEST

Guaifenesin
$0.0606per ML
OTC

Strength

400 mg/20mL

Manufacturer

RB Health (US) LLC

NDC

63824053766

Classification

Brand

Dosage Form

SOLUTION

Route

ORAL

Last Updated

4/1/2022

Active Ingredients

GUAIFENESIN

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

6/1/2020

Pharmacological Classes

Decreased Respiratory Secretion Viscosity
Expectorant
Increased Respiratory Secretions

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

N/A

All

+16.7%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

ADT ROBITUSSIN PEAK CLD M-S LQ
Brand
00031874220•Haleon US Holdings LLC
$0.0284
per ML
VICKS DAYQUIL SEVERE COLD-FLU
Brand
37000081008•The Procter & Gamble Manufacturing Company
$0.0303
per ML
ADT ROBITUSSIN PEAK CLD M-S LQ
Brand
00031874214•Haleon US Holdings LLC
$0.0368
per ML
ROBITUSSIN COUGH-COLD CF LIQ
Brand
00031871612•Haleon US Holdings LLC
$0.0372
per ML
CHILD MUCINEX MULTI-SYMPTOM LQ
Brand
63824028267•RB Health (US) LLC
$0.0460
per ML
MUCINEX FAST-MAX DM MAX LIQUID
Brand
63824001966•RB Health (US) LLC
$0.0614
per ML
DELSYM COUGH+CHEST CNGST DM LQ
Brand
63824021366•RB Health (US) LLC
$0.0614
per ML
MUCINEX FAST-MAX DM MAX LIQUID
Brand
63824053566•RB Health (US) LLC
$0.0614
per ML
MUCINEX FAST-MAX CONGEST-COUGH
Brand
63824054066•RB Health (US) LLC
$0.0615
per ML
MUCINEX COLD-FLU-SORETHROAT LQ
Brand
63824001566•RB Health (US) LLC
$0.0621
per ML

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy